Coping Strategies of Patients With Advanced Lung or Colorectal Cancer Over Time: Insights From the International ACTION Study.


Journal

Psycho-oncology
ISSN: 1099-1611
Titre abrégé: Psychooncology
Pays: England
ID NLM: 9214524

Informations de publication

Date de publication:
Oct 2024
Historique:
revised: 04 09 2024
received: 04 04 2024
accepted: 15 09 2024
medline: 4 10 2024
pubmed: 4 10 2024
entrez: 4 10 2024
Statut: ppublish

Résumé

A comprehensive understanding of coping strategies of patients with advanced diseases can contribute to providing supportive care that meets patients' needs. However, insight into how coping of this population develops over time is lacking. We examined coping strategies of patients with advanced cancer over time and identified distinct trajectories and their predictors. Data from 675 patients of the control group from the ACTION cluster-randomized trial were analyzed. Patients with lung or colorectal cancer from six European countries (Belgium, Denmark, Italy, the Netherlands, Slovenia and the United Kingdom) completed questionnaires at baseline, 12 and 20 weeks. Measures included Denial, Acceptance, and Problem-focused coping (COPE, Brief COPE inventory; scores 4-16 per scale). We used linear mixed models to analyze the data and latent class mixed models to identify stable (within patient change < 2) coping strategies. At baseline, patients reported low use of Denial (6.6) and greater use of Acceptance (12.6) and Problem-Focused coping (12.2). These scores did not significantly change. We found four distinct trajectories for the use of Denial, three for Acceptance and five for Problem-Focused coping strategies. Stable trajectories were found in 513 (77%) patients for Denial, 645 (96%) for Acceptance and 602 (91%) for Problem-Focused coping. All coping strategies were stable in 447 (68%) patients and two were stable in 181 patients (28%). Overall, the use of coping strategies was rather stable in the majority of patients with advanced cancer. However, for each of the coping strategies subgroups of patients reported fluctuating coping trajectories.

Identifiants

pubmed: 39363364
doi: 10.1002/pon.9315
doi:

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

e9315

Subventions

Organisme : The ACTION trial was supported by the European Union's 7th Framework Programme for Research and Technological Development.
ID : 602541-2

Informations de copyright

© 2024 The Author(s). Psycho‐Oncology published by John Wiley & Sons Ltd.

Références

J. A. Greer, A. J. Applebaum, J. C. Jacobsen, J. S. Temel, and V. A. Jackson, “Understanding and Addressing the Role of Coping in Palliative Care for Patients With Advanced Cancer,” Journal of Clinical Oncology 38, no. 9 (2020): 915–925, https://doi.org/10.1200/jco.19.00013.
S. Kaasa and J. H. Loge, “Quality of Life in Palliative Care: Principles and Practice,” Palliative Medicine 17, no. 1 (2003): 11–20, https://doi.org/10.1191/0269216303pm662ra.
R. D. Nipp, A. El‐Jawahri, J. N. Fishbein, et al., “The Relationship Between Coping Strategies, Quality of Life, and Mood in Patients With Incurable Cancer,” Cancer 122, no. 13 (2016): 2110–2116, https://doi.org/10.1002/cncr.30025.
J. A. Greer, J. M. Jacobs, A. El‐Jawahri, et al., “Role of Patient Coping Strategies in Understanding the Effects of Early Palliative Care on Quality of Life and Mood,” Journal of Clinical Oncology 36, no. 1 (2018): 53–60, https://doi.org/10.1200/jco.2017.73.7221.
T. G. Thomsen, S. Rydahl‐Hansen, and L. Wagner, “A Review of Potential Factors Relevant to Coping in Patients With Advanced Cancer,” Journal of Clinical Nursing 19, no. 23–24 (2010): 3410–3426.
R. S. Lazarus, “Coping Theory and Research: Past, Present, and Future,” Psychosomatic Medicine 55, no. 3 (1993): 234–247.
C. S. Carver, M. F. Scheier, and J. K. Weintraub, “Assessing Coping Strategies: A Theoretically Based Approach,” Journal of Personality and Social Psychology 56, no. 2 (1989): 267–283, https://doi.org/10.1037/0022‐3514.56.2.267.
C. S. Carver and J. Connor‐Smith, “Personality and Coping,” Annual Review of Psychology 61, no. 1 (2010): 679–704, https://doi.org/10.1146/annurev.psych.093008.100352.
S. E. Taylor and A. L. Stanton, “Coping Resources, Coping Processes, and Mental Health,” Annual Review of Clinical Psychology 3, no. 1 (2007): 377–401, https://doi.org/10.1146/annurev.clinpsy.3.022806.091520.
J. A. Litman, “The COPE Inventory: Dimensionality and Relationships With Approach‐and Avoidance‐Motives and Positive and Negative Traits,” Personality and Individual Differences 41, no. 2 (2006): 273–284, https://doi.org/10.1016/j.paid.2005.11.032.
L. J. Jabbarian, I. J. Korfage, B. Červ, et al., “Coping Strategies of Patients With Advanced Lung or Colorectal Cancer in Six European Countries: Insights From the ACTION Study,” Psycho‐Oncology 29, no. 2 (2020): 347–355, https://doi.org/10.1002/pon.5259.
I. Henoch, B. Bergman, M. Gustafsson, F. Gaston‐Johansson, and E. Danielson, “The Impact of Symptoms, Coping Capacity, and Social Support on Quality of Life Experience Over Time in Patients With Lung Cancer,” Journal of Pain and Symptom Management 34, no. 4 (2007): 370–379, https://doi.org/10.1016/j.jpainsymman.2006.12.005.
V. L. Beesley, D. D. Smith, C. M. Nagle, et al., “Coping Strategies, Trajectories, and Their Associations With Patient‐Reported Outcomes Among Women With Ovarian Cancer,” Supportive Care in Cancer 26, no. 12 (2018): 4133–4142, https://doi.org/10.1007/s00520‐018‐4284‐0.
H. W. M. van Laarhoven, J. Schilderman, G. Bleijenberg, et al., “Coping, Quality of Life, Depression, and Hopelessness in Cancer Patients in a Curative and Palliative, End‐of‐Life Care Setting,” Cancer Nursing 34, no. 4 (2011): 302–314, https://doi.org/10.1097/ncc.0b013e3181f9a040.
N. S. Endler, N. L. Kocovski, and S. D. Macrodimitris, “Coping, Efficacy, and Perceived Control in Acute vs Chronic Illnesses,” Personality and Individual Differences 30, no. 4 (2001): 617–625, https://doi.org/10.1016/s0191‐8869(00)00060‐x.
M. H. McConnell, M. Miljanovski, G. Rodin, and M.‐F. O’Connor, “Measuring Double Awareness in Patients With Advanced Cancer: A Preliminary Scale Development Study,” Palliative & Supportive Care (2023): 1–6, https://doi.org/10.1017/s1478951523001669.
G. Rodin and C. Zimmermann, “Psychoanalytic Reflections on Mortality: A Reconsideration,” Journal of the American Academy of Psychoanalysis and Dynamic Psychiatry 36, no. 1 (2008): 181–196, https://doi.org/10.1521/jaap.2008.36.1.181.
U. S. Schuler and B. Hornemann, eds., Hope and Double Awareness in Palliative Oncology. Forum (Berlin: Springer, 2020).
R. H. Moos and C. J. Holahan, “Dispositional and Contextual Perspectives on Coping: Toward an Integrative Framework,” Journal of Clinical Psychology 59, no. 12 (2003): 1387–1403, https://doi.org/10.1002/jclp.10229.
P. Roussi, V. Krikeli, C. Hatzidimitriou, and I. Koutri, “Patterns of Coping, Flexibility in Coping and Psychological Distress in Women Diagnosed With Breast Cancer,” Cognitive Therapy and Research 31, no. 1 (2007): 97–109, https://doi.org/10.1007/s10608‐006‐9110‐1.
K. Baumstarck, O. Chinot, E. Tabouret, et al., “Coping Strategies and Quality of Life: A Longitudinal Study of High‐Grade Glioma Patient‐Caregiver Dyads,” Health and Quality of Life Outcomes 16, no. 1 (2018): 1–10, https://doi.org/10.1186/s12955‐018‐0983‐y.
M. S. Vos, H. Putter, H. C. van Houwelingen, and H. C. J. M. de Haes, “Denial in Lung Cancer Patients: A Longitudinal Study,” Psycho‐Oncology 17, no. 12 (2008): 1163–1171, https://doi.org/10.1002/pon.1325.
J. A. C. Rietjens, I. J. Korfage, L. Dunleavy, et al., “Advance Care Planning–A Multi‐Centre Cluster Randomised Clinical Trial: The Research Protocol of the ACTION Study,” BMC Cancer 16, no. 1 (2016): 1–8, https://doi.org/10.1186/s12885‐016‐2298‐x.
I. J. Korfage, G. Carreras, C. M. Arnfeldt Christensen, et al., “Advance Care Planning in Patients With Advanced Cancer: A 6‐Country, Cluster‐Randomised Clinical Trial,” PLoS Medicine 17, no. 11 (2020): e1003422, https://doi.org/10.1371/journal.pmed.1003422.
C. S. Carver, “You Want to Measure Coping but Your Protocol’too Long: Consider the Brief Cope,” International Journal of Behavioral Medicine 4, no. 1 (1997): 92–100, https://doi.org/10.1207/s15327558ijbm0401_6.
C. B. Terwee, S. D. M. Bot, M. R. de Boer, et al., “Quality Criteria Were Proposed for Measurement Properties of Health Status Questionnaires,” Journal of Clinical Epidemiology 60, no. 1 (2007): 34–42, https://doi.org/10.1016/j.jclinepi.2006.03.012.
Muthén B. and D. Kaplan, Handbook of Quantitative Methodology for the Social Sciences. (Newcastle upon Tyne: Sage, 2004).
K. L. Nylund, T. Asparouhov, and B. O. Muthén, “Deciding on the Number of Classes in Latent Class Analysis and Growth Mixture Modeling: A Monte Carlo Simulation Study,” Structural Equation Modeling: A Multidisciplinary Journal 14, no. 4 (2007): 535–569, https://doi.org/10.1080/10705510701575396.
G. Rodin, C. Lo, A. Rydall, et al., “Managing Cancer and Living Meaningfully (CALM): A Randomized Controlled Trial of a Psychological Intervention for Patients With Advanced Cancer,” Journal of Clinical Oncology 36, no. 23 (2018): 2422–2432, https://doi.org/10.1200/jco.2017.77.1097.
S. C. Danhauer, S. L. Crawford, D. F. Farmer, and N. E. Avis, “A Longitudinal Investigation of Coping Strategies and Quality of Life Among Younger Women With Breast Cancer,” Journal of Behavioral Medicine 32, no. 4 (2009): 371–379, https://doi.org/10.1007/s10865‐009‐9211‐x.
M.‐S. Paek, E. H. Ip, B. Levine, and N. E. Avis, “Longitudinal Reciprocal Relationships Between Quality of Life and Coping Strategies Among Women With Breast Cancer,” Annals of Behavioral Medicine 50, no. 5 (2016): 775–783, https://doi.org/10.1007/s12160‐016‐9803‐y.
O. McSorley, E. McCaughan, G. Prue, K. Parahoo, B. Bunting, and J. O'Sullivan, “A Longitudinal Study of Coping Strategies in Men Receiving Radiotherapy and Neo‐Adjuvant Androgen Deprivation for Prostate Cancer: A Quantitative and Qualitative Study,” Journal of Advanced Nursing 70, no. 3 (2014): 625–638, https://doi.org/10.1111/jan.12224.
M. S. Vos, H. Putter, H. C. van Houwelingen, and H. C. J. M. de Haes, “Denial and Social and Emotional Outcomes in Lung Cancer Patients: The Protective Effect of Denial,” Lung Cancer 72, no. 1 (2011): 119–124, https://doi.org/10.1016/j.lungcan.2010.07.007.
J. S. Temel, J. A. Greer, A. Muzikansky, et al., “Early Palliative Care for Patients With Metastatic Non–Small‐Cell Lung Cancer,” New England Journal of Medicine 363, no. 8 (2010): 733–742, https://doi.org/10.1056/nejmoa1000678.
J. S. Temel, J. A. Greer, A. El‐Jawahri, et al., “Effects of Early Integrated Palliative Care in Patients With Lung and GI Cancer: A Randomized Clinical Trial,” Journal of Clinical Oncology 35, no. 8 (2017): 834–841, https://doi.org/10.1200/jco.2016.70.5046.
M. Bakitas, K. D. Lyons, M. T. Hegel, et al., “Effects of a Palliative Care Intervention on Clinical Outcomes in Patients With Advanced Cancer: The Project ENABLE II Randomized Controlled Trial,” Journal of the American Medical Association 302, no. 7 (2009): 741–749, https://doi.org/10.1001/jama.2009.1198.
C. Zimmermann, N. Swami, M. Krzyzanowska, et al., “Early Palliative Care for Patients With Advanced Cancer: A Cluster‐Randomised Controlled Trial,” Lancet 383, no. 9930 (2014): 1721–1730, https://doi.org/10.1016/s0140‐6736(13)62416‐2.
J. A. Greer, W. F. Pirl, V. A. Jackson, et al., “Effect of Early Palliative Care on Chemotherapy Use and End‐of‐Life Care in Patients With Metastatic Non–Small‐Cell Lung Cancer,” Journal of Clinical Oncology 30, no. 4 (2011): 394–400, https://doi.org/10.1200/jco.2011.35.7996.
K. R. Ellis, M. R. Janevic, T. Kershaw, C. H. Caldwell, N. K. Janz, and L. Northouse, “Meaning‐Based Coping, Chronic Conditions and Quality of Life in Advanced Cancer & Caregiving,” Psycho‐Oncology 26, no. 9 (2017): 1316–1323, https://doi.org/10.1002/pon.4146.

Auteurs

K L Luu (KL)

Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.

P Mager (P)

Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.

D Nieboer (D)

Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.

F E Witkamp (FE)

Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.
Research Centre Innovations in Care, Rotterdam University of Applied Sciences, Rotterdam, the Netherlands.

L J Jabbarian (LJ)

Department of Psychiatry, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.

S Payne (S)

International Observatory on End of Life Care, Division of Health Research, Faculty of Health and Medicine, Lancaster University, Lancaster, UK.

M Groenvold (M)

Palliative Care Research Unit, Department of Geriatrics and Palliative Medicine GP, Bispebjerg & Frederiksberg Hospital, Copenhagen, Denmark.
Department of Public Health, University of Copenhagen, Copenhagen, Denmark.

K Pollock (K)

School of Health Sciences, University of Nottingham, Nottingham, UK.

G Miccinesi (G)

Oncological Network, Prevention and Research Institute (ISPRO), Florence, Italy.

L Deliens (L)

Vrije Universiteit Brussel & Ghent University, End-of-Life Care Research Group, Brussels, Ghent, Belgium.

J J M van Delden (JJM)

Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.

A van der Heide (A)

Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.

I J Korfage (IJ)

Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.

J A C Rietjens (JAC)

Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.
Department of Design, Organization and Strategy, Faculty of Industrial Design Engineering, Delft University of Technology, Delft, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH